MedPath

Philippines FDA Approvals

FDA Philippines approved pharmaceutical products and drug approvals

Food and Drug Administration of the Philippines
Philippines
30,876 Approvals
Showing 30561 to 30580 of 30,876 approvalsPage 1529 of 1544

Rapid-B + E

Issued: Feb 1, 2022

None

Issued: Feb 1, 2022

Merrox

Issued: Feb 1, 2022

Zynapse 1000

Issued: Feb 1, 2022

Cofnil

Issued: Feb 1, 2022

None

Issued: Feb 1, 2022

Clavsin

Issued: Feb 1, 2022

Hemotran

Issued: Feb 1, 2022

Cefexil

Issued: Feb 1, 2022

Breathy Nasal Spray

Issued: Feb 1, 2022
PT. Novell Pharmaceutical Laboratories

Metrovin

Issued: Feb 1, 2022

Sutent

Issued: Feb 1, 2021

Coxid

Issued: Feb 1, 2021

Grovixin 625

Issued: Feb 1, 2021

Adresone

Issued: Feb 1, 2021

Tandol

Issued: Feb 1, 2021

Moxsea

Issued: Feb 1, 2021

Seamoxiclav

Issued: Feb 1, 2021

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.